This inventor holds 1 USPTO granted patent. Top assignee: Beijing University of Technology. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Baydaa Hirmiz: Innovator in Fibrosis Treatment
Introduction
Baydaa Hirmiz is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of medical research, particularly in the treatment of fibrosis. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Hirmiz holds a patent for "Angiotensin receptor agonists and uses thereof." This invention relates to compositions, methods, and kits designed for the treatment of fibrosis, with a specific focus on cardiac fibrosis. The invention provides a method of treating fibrosis in an individual by administering an AT2R selective agonist, thereby effectively addressing the condition.
Career Highlights
Baydaa Hirmiz is affiliated with the Beijing University of Technology, where he continues to advance his research and innovation in the medical field. His work is characterized by a commitment to improving health outcomes through scientific discovery.
Collaborations
Hirmiz has collaborated with esteemed colleagues, including Robert Edward Widdop and Marie-Isabel Aguilar. These partnerships have fostered a collaborative environment that enhances the impact of their research.
Conclusion
Baydaa Hirmiz is a pioneering inventor whose work in fibrosis treatment exemplifies the intersection of innovation and healthcare. His contributions are vital in the ongoing quest to improve medical treatments and patient outcomes.